| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.0044 | 1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.006 | 1 |